⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PMN News
ProMIS Neurosciences Inc. Common Shares (ON)
ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026
globenewswire.com
PMN
Form 8-K
sec.gov
PMN
ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial
globenewswire.com
PMN
ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease
globenewswire.com
PMN
ProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026
globenewswire.com
PMN
ProMIS Neurosciences to Participate in Upcoming Conferences in June
globenewswire.com
PMN
Form 8-K
sec.gov
PMN
Form 8-K
sec.gov
PMN
ProMIS Neurosciences Announces First Quarter 2026 Financial Results and Provides Corporate Highlights
globenewswire.com
PMN
ProMIS Neurosciences Invited to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference Ready to Announce with Confidence?
newsfilecorp.com
PMN